&Partners’s Neogen NEOG Stock Holding History

&Partners’s Portfolio NEOG Stock Details NEOG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$507K	Buy	56,436 +2,070	+4%	+$19K	﹤0.01%	1820
2026 Q1	$505K	Buy	54,366 +11,797	+28%	+$116K	﹤0.01%	1685
2025 Q4	$367K	Sell	42,569 -3,874	-8%	-$24.4K	﹤0.01%	1791
2025 Q3	$265K	Buy	46,443 +8,429	+22%	+$45K	﹤0.01%	1821
2025 Q2	$182K	Buy	38,014 +1,384	+4%	+$7.94K	﹤0.01%	1851
2025 Q1	$316K	Buy	36,630 +1,518	+4%	+$15.9K	﹤0.01%	1380
2024 Q4	$430K	Buy	35,112 +11,771	+50%	+$165K	0.01%	1141
2024 Q3	$392K	Buy	+23,341	New	+$384K	0.01%	972

Other funds holding NEOG

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

ING Group Amsterdam, Netherlands $20.5B AUM 49.71% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GCM

Gates Capital Management New York $4.16B AUM 21% 1-Year Est. Return

&Partners's NEOG Position: Q2 2026 in Review

&Partners increased its Neogen (NEOG) stake by 3.8% in Q2 2026, buying an estimated $19K and bringing the position to 56,436 shares worth $507K. The position accounts for ﹤0.01% of the portfolio, ranked #1820.

&Partners first reported a position in NEOG in Q3 2024 and has held it in 8 quarters since. 317 funds tracked by Wall St. Rank hold NEOG as of Q2 2026.

&Partners held 56,436 shares of Neogen worth $507K as of Q2 2026.
&Partners bought 2,070 Neogen shares in Q2 2026, an estimated $19K.
Neogen made up ﹤0.01% of &Partners's portfolio in Q2 2026, its #1820 holding.
&Partners first reported a position in Neogen in Q3 2024 and has held it in 8 quarters since.
317 funds tracked by Wall St. Rank held Neogen as of Q2 2026.

Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.